Max Behrens, Janis M. Nolde, Eleni Papakonstantinou +6stat.ME stat.ML
Prognostic regression models often synthesize data from multiple sites, whether within a multi-site study, across federated settings, or in individual participant data meta-analysis. Here, a site is any data source, such as a hospital, registry, trial, or study, and need not be a physical center. Analysts must then decide whether one regression model represents all sites or whether site-specific models are needed. Established measures such as coefficient-level tau^2 quantify heterogeneity but do not distinguish its source. We focus on diagnosing whether coefficient heterogeneity reflects case-mix or site-specific context effects. Case-mix heterogeneity can arise when linear regression terms approximate multivariable non-linear relationships in populations with different covariate distributions. Contextual heterogeneity arises when comparable patients require different regression relationships across sites. We do this by fitting site-specific local regressions in a dimension-reduced space and partitioning the smoothed coefficient surfaces into a cross-site reference and site-specific deviations. An autoencoder and custom loss structure the latent space around local prognostic relationships. We then project this partition onto the outcome scale to derive observation- and site-level summaries. We demonstrate the approach on a COPD trial with two sites. In the three leading latent slope coordinates, coefficient-surface variation was predominantly contextual. The derived observation-level outcome-scale variance partition was case-mix-leading, whereas its between-site aggregation was concentrated in contextual differences rather than case-mix shifts. A permuted-site negative control assesses whether the contextual summary can arise when site labels carry no signal. This diagnostic distinction can inform whether joint or site-specific regression models should be evaluated.
Siyuan Du, Mengxi Chen, Xinyang Jiang +6cs.LG cs.CV
Although artificial intelligence (AI) has shown promising performance in several medical tasks, accurate dementia etiology diagnosis with AI remains challenging due to complex overlapping symptoms among diseases. Scaling up the dataset size by combining the cross-center samples may bring a gain in the pursuit of performance, while the inherent data heterogeneity across centers or populations induces the conflict. Conventional multi-task learning paradigms offer a promising framework; however, they fail to consider critical meta information (e.g., site-specific acquisition and modality availability) to combat the heterogeneity. To address this challenge, we propose a Collaborative Meta Knowledge Enhancement (COME) framework for dementia etiology diagnosis, which injects multi-center acquisition semantics, source identifiers, and modality indicators as heterogeneity-aware embeddings into a unified Transformer architecture for scale-up training, enabling explicit modeling of heterogeneity. Besides, a trust-region constrained optimization scheme is designed to regularize the model from spurious correlations during training through a reference model. Across seven independent cohorts, our method achieves state-of-the-art in-domain performance with a mean macro-averaged AUC of 85.62% and a 4.29-point gain over the strongest baseline, while maintaining superior out-of-domain generalization under both cross-center and cross-sequence evaluations. Extensive validation also confirms the alignment between model predictions and established biomarkers (amyloid, tau) and clinical severity, highlighting the potential of COME to enable robust and interpretable dementia diagnostics in real-world settings.